Document Detail


Cholesterol lowering and the reduction of CHD incidence and total mortality: results from a meta-analysis of randomized trials.
MedLine Citation:
PMID:  1390319     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This editorial reports on a meta-analysis done on cholesterol-lowering trials. Coronary heart disease incidence is reported for 16 trials and total mortality for 19 trials. The cholesterol benefit ratio, i.e., the percent risk reduction divided by the percent cholesterol reduction, was analyzed in terms of total vs. potential modifying factors. For coronary heart disease the benefit ratio was 2.8 (95% CL: 1.5, 4.2), and for total mortality it was 1.2 (95% CL: -0.1, 2.3). Cholesterol reduction had to be at least 8-9% to outweigh the negative impact of treatment on total mortality.
Authors:
I Holme
Related Documents :
24217829 - A less aggressive therapeutic option for electrical storm.
8348819 - Accelerated cholesterol synthesis in the monocytes of young myocardial infarction survi...
9550499 - Cholesterol lowering in the management of coronary artery disease: the clinical implica...
15465509 - Effects of statins on stroke prevention in patients with and without coronary heart dis...
12510249 - Treatment of arteriosclerosis.
7572689 - Reduction in coronary events during treatment with pravastatin. plac i and plac ii inve...
21670229 - Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with redu...
8002859 - Predictors of survival after cerebral infarction: importance of cardiac factors.
22879049 - Targeted delivery of vegf to treat myocardial infarction.
Publication Detail:
Type:  Editorial    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  6     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-11-10     Completed Date:  1992-11-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  101-2     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cholesterol / blood*
Coronary Disease / mortality,  prevention & control*
Humans
Meta-Analysis as Topic
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer.
Next Document:  Cholesterol biosynthesis and metabolism.